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Dear Editor,
Doxorubicin is an anthracycline antibiotic, which is used
in treatment of cancer and it works by induction of apoptosis in
cancerous cells.1 In vivo, apoptotic cells are rapidly cleared
preferentially by monocytes and neutrophil migration is
inhibited2 to limit tissue injury and inflammation. More
recently, few anti-cancer drugs, including anthracyclines
(doxorubicin) were shown to evoke apoptosis in cancerous
cells, which is associated with immune system activation
(i.e. immunogenic apoptosis).3,4 In our previous study we
reported that doxorubicin can induce acute inflammation in
peritoneum, which is associated with apoptosis.5 Doxorubi-
cin-killed cells could be also a source of damage-associated
molecular patterns (DAMPs) leading to inflammation and
tumor necrosis factor (TNF) production, which would amplify
the inflammatory response triggered by DAMPs. TNF is a
pleiotropic cytokine that binds to receptors TNF-R1 and
TNF-R2 and, depending on cell type, triggers different
signaling pathways, including cell death and inflammation.6
This study aimed to examine whether TNF contributes to the
doxorubicin-induced acute sterile inflammation.
Intraperitoneal injection of doxorubicin provoked an acute
inflammatory response accompanied by the influx of neutro-
phils.5 We observed an increased level of LDH, a marker of
tissue damage and secondary necrotic cells, already after 6 h
with further increase after 16 h post injection of doxorubicin
(Supplementary Figure 1a). Lavage fluid collected 16 h after
doxorubicin injection contained increased levels of TNF as
compared to vehicle-injected group (0.09±0.14 versus
2.11±0.84 pg/ml, Po0.0001).
We next tested the involvement of TNF-R1 and TNF-R2 in
the sterile inflammation in response to doxorubicin. Wild-type
mice had abundant neutrophils in their abdominal cavities,
but this response was markedly decreased in TNF-R1/2
double knockout mice (by 2.4-fold, Supplementary Figure 1b).
The number of neutrophils attracted in response to
doxorubicin-induced acute inflammation was 3.4-fold lower
in TNF-R1-deficient mice than in controls (Figure 1a), but in
TNF-R2-deficient mice, there was no difference as compared
to wild-typemice (Figure 1b). These results show that TNF-R1
was involved in mediating the inflammatory response but
TNF-R2 was not. Importantly, cell death in TNF-R1/2 double
knockout mice was not affected in comparison to wild-type
mice (data not shown) indicating that TNF does not contribute
to the cell death process itself.
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Figure 1 Role of TNF-R1 and TNF-R2 and the effect of inhibiting soluble TNF
on doxorubicin-induced acute inflammatory response. The number of neutrophils in
peritoneal lavage was decreased in TNF-R1 / (a) but not in TNF-R2 / (b).
Treatment of wild-type mice with Etanercept significantly reduced the recruitment of
neutrophils 16 h after intraperitoneal injection of doxorubicin (DoxþE) (c). Negative
controls were injected with vehicle alone or with vehicle plus Enanercept (VehþE).
Means and S.E.M. are for pooled data, and n is the number of mice in each group.
**Po0.002. Mann–Whitney test was used to evaluate differences between groups
(GraphPad Prism-5). The number of monocytes/macrophages and neutrophils in
the peritoneal exudate cells was determined as described previously.5
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Further, we investigated whether acute inflammation
can be reduced in wild-type mice by the administration of
Etanercept, a recombinant dimeric soluble form of TNF-R2
that blocks the interaction of TNF with its cell surface
receptors.7 Wild-type mice were injected intraperitoneally
with Etanercept together with doxorubicin and 16 h later the
recruited cells were phenotyped. Etanercept significantly
reduced the recruitment of neutrophils (Figure 1c). This
further confirms the importance of TNF in doxorubicin-
induced acute inflammation.
In conclusion, we report that intraperitoneal injection
of doxorubicin in mice leads to increase in TNF levels in the
lavage fluid. It has been also reported that patients
undergoing chemotherapy with doxorubicin had elevated
levels of TNF in their plasma.8 Similarly, mouse in vitro and
in vivo studies demonstrated up-regulation of TNF after
doxorubicin administration both on mRNA and protein
levels.9,10 Previously, we found that the majority of cells that
died apoptotically due to doxorubicin treatment were mono-
cytes/macrophages with some minor neutrophils.5 Therefore,
it is possible that either dying macrophages or attracted
neutrophils might be a source of TNF, and that by binding to
TNF-R1 it could amplify the inflammation. We demonstrated
that the acute inflammatory response to doxorubicin
was reduced in TNF-R1- but not TNF-R2-deficient mice. In
addition, Etanercept decreases the attraction of neutrophils
after doxorubicin administration. These studies show that
TNF and the TNF-R1 signaling pathway are key elements in
the acute sterile inflammatory response to doxorubicin.
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